| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2500022 | 静注人免疫球蛋白(10%) | human immunoglobulin(PH4) | Injection | Biological Products(3.2) | New Drug Application | 2025-01-08 | Guangdong Shuanglin Bio-Pharmacy Co Ltd | view | |||
| CYSB2300149 | 静注人免疫球蛋白(10%) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2023-08-02 | Guangdong Shuanglin Bio-Pharmacy Co Ltd | view |